Immune cell therapy shows early promise for patients with pancreatic cancer
A nonengineered, multiantigen-specific T-cell therapy was safe, tolerable, and showed signs of clinical activity in patients who had pancreatic adenocarcinoma, according to preliminary results from a phase I clinical trial ...
Jul 22, 2019
0
4